⌘K

Login Start Free

Home/Filings/4/0001615774-18-001626

4//SEC Filing

Mir Conrad F 4

Accession 0001615774-18-001626

CIK 0000102198other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 1:09 PM ET

Size

7.0 KB

Accession

0001615774-18-001626

Insider Transaction Report

Form 4

Period: 2018-02-12

CALMARE THERAPEUTICS IncCTTC

DirectorPresident, CEO and Interim CFO

Transactions

Exercise/Conversion
Common Stock
2018-02-12$0.08/sh+1,000,000$80,000→ 1,440,751 total
Exercise/Conversion
Option
2018-02-12$0.08/sh+1,000,000$80,000→ 1,000,000 total
Exercise: $0.08→ Common Stock (1,000,000 underlying)

Footnotes (1)

[F1]A stock option to purchase 1,000,000 shares at an exercise price of $0.08 was granted on 10/1/2013. 20% of this option vested on 10/1/2013, 10/1/2014, 10/1/2015, 10/1/2016 and 10/1/2017, respectively.

Documents

1 file

4
s109138_4.xmlPrimary
4

Issuer

CALMARE THERAPEUTICS Inc

CIK 0000102198

Entity typeother

Related Parties

1

filerCIK 0001564655

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 1:09 PM ET
Size: 7.0 KB

View on SEC.gov